Skip to content
AnalystLens

Tenet Healthcare 8-K Report, Regulation FD Disclosure (Feb 29, 2024)

Reports
Regulation FD·Other Events·Exhibits & Filings
Filing Date
Filed February 29, 2024
Period End
February 29, 2024
Security
THC
In the record · 2016–202610-K1110-Q338-K176

THC filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 176 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Jan ’19Jan ’19
  2. Deal closed8-K · Dec ’20Dec ’20
  3. Leadership change8-K · Oct ’22Oct ’22
  4. Material agreement8-K · Sep ’26Sep ’26

Summary

Summary of the 8-K filed February 29, 2024. Cited figures are marked; the original filing is the authoritative source.

Tenet Healthcare Corporation (NYSE: THC) announced on February 29, 2024 a definitive agreement to sell two California hospitals, Sierra Vista Regional Medical Center and Twin Cities Community Hospital, along with certain related operations, to Adventist Health for $550 milliona in cash (after-tax proceeds of approximately $450 million).

The transaction is not subject to a financing contingency, is subject to customary closing conditions including Hart-Scott-Rodino clearance, and is anticipated to close in the spring of 2024. Purchase price adjustments for working capital and other items are customary. For the year ended December 31, 2023, the divested hospitals and related operations generated revenues of approximately $337 millionb, pre-tax income of approximately $25 million, and Adjusted EBITDA of approximately $38 million, excluding depreciation and amortization expense of approximately $13 million.

The company estimates recording a pre-tax book gain of approximately $275 millionc on the transaction. Alongside the sale, Tenet's Conifer Health Solutions subsidiary will enter into a contract to provide hospital and physician revenue cycle services to Adventist Health.

The company describes this relationship as covering over $3.5 billiond in net revenue. The 8-K is furnished under Item 7.01 and filed under Item 8.01, with the press release attached as Exhibit 99.1.

Key Highlights

  1. Agreed sale of Sierra Vista Regional Medical Center and Twin Cities Community Hospital, plus related operations, to Adventist Health for $550 million in cash
  2. Approximately $450 million in after-tax proceeds expected from the transaction
  3. Estimated pre-tax book gain of approximately $275 million upon closing
  4. Divested operations generated approximately $337 million in revenues and approximately $38 million in Adjusted EBITDA for 2023
  5. Conifer Health Solutions to provide revenue cycle services to Adventist Health, covering over $3.5 billion in net revenue
  6. No financing contingency; closing subject to customary conditions including Hart-Scott-Rodino waiting period expiration
  7. Transaction anticipated to close in the spring of 2024

Frequently Asked Questions

  1. What is being sold and to whom?

    Tenet is selling two hospitals in California, Sierra Vista Regional Medical Center and Twin Cities Community Hospital, along with certain related operations, to Adventist Health for $550 million in cash.

  2. What financial impact is expected from the sale?

    The company estimates a pre-tax book gain of approximately $275 million and after-tax proceeds of approximately $450 million.

  3. How large are the divested operations?

    For the year ended December 31, 2023, the hospitals and related operations generated revenues of approximately $337 million, pre-tax income of approximately $25 million, and Adjusted EBITDA of approximately $38 million, excluding depreciation and amortization of approximately $13 million.

  4. What is the Conifer Health Solutions role in the deal?

    Conifer Health Solutions, Tenet's subsidiary, will enter into a contract to provide hospital and physician revenue cycle services to Adventist Health, which the company describes as covering over $3.5 billion in net revenue.

  5. When is the transaction expected to close and what could delay it?

    The transaction is anticipated to close in the spring of 2024. Completion is subject to closing conditions, including expiration or termination of the Hart-Scott-Rodino waiting period and other regulatory or governmental filings and approvals.